Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reliant Omacor Launch Funded Through IPO; Launch Set For Late 2005

Executive Summary

Reliant Pharmaceuticals will raise cash through an initial public offering to pay for a sales force expansion for the launch of the triglyercide therapy Omacor

You may also be interested in...



Omacor medication errors

The Institute of Safe Medication Practices is recommending that the name of Reliant's hypertriglyceridemia therapy Omacor (omega-3-acid ethyl esters) be changed due to similarity with Xanodyne's antifibrinolytic agent Amicar (aminocaproic acid). "Prescriptions for Omacor have just begun to arrive in pharmacies, but we've already heard name-related safety issues. A pharmacist reported an error in which a telephone order of Omacor 1 g B.I.D. was misheard as Amicar 1 g B.I.D.," the Nov. 3 issue of ISMP's Medication Safety Alert! says. Reliant launched Omacor in October, following approval in November 2004 (1"The Pink Sheet" June 6, 2005, p. 9)...

Omacor medication errors

The Institute of Safe Medication Practices is recommending that the name of Reliant's hypertriglyceridemia therapy Omacor (omega-3-acid ethyl esters) be changed due to similarity with Xanodyne's antifibrinolytic agent Amicar (aminocaproic acid). "Prescriptions for Omacor have just begun to arrive in pharmacies, but we've already heard name-related safety issues. A pharmacist reported an error in which a telephone order of Omacor 1 g B.I.D. was misheard as Amicar 1 g B.I.D.," the Nov. 3 issue of ISMP's Medication Safety Alert! says. Reliant launched Omacor in October, following approval in November 2004 (1"The Pink Sheet" June 6, 2005, p. 9)...

Reliant Will Add Antara, Omacor To Cardiovascular Product Line In 2005

Reliant will launch two recently-approved cardiovascular products, Antara and Omacor, in 2005

Related Content

Topics

UsernamePublicRestriction

Register

PS045910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel